Journal of Hepatology
Volume 51, Issue 6 , Pages 1074-1081, December 2009

Vinyl chloride and the liver

Department of Medicine, University of Toronto, Rm. # NCSB 11C 1252, 585 University Avenue, Toronto, Ont., Canada M5G 2N2

Received 20 August 2009; received in revised form 16 September 2009; accepted 18 September 2009. published online 01 October 2009.

Associate Editor: M. Colombo

Vinyl chloride monomer is a known cause of angiosarcoma of the liver. It also has other toxic effects on the liver, and it has recently been suggested that exposure to vinyl chloride also causes hepatocellular carcinoma. However, the data on which this conclusion is based is incomplete. There is inadequate ascertainment of unequivocal diagnoses. In the largest studies lack of data meant that confounding diseases such as viral hepatitis or alcoholic liver disease could not be assessed. At best, the increase in risk is minimal, based on more than 22,000 exposed workers and more than 640,000 person years of observation.

However, based on the available data the hypothesis that vinyl chloride causes or contributes to the development of hepatocellular carcinoma remains unproven.

Keywords: Vinyl chloride, Hepatocellular carcinoma, Angiosarcoma

Abbreviations: VCM, vinyl chloride monomer, PVC, polyvinyl chloride, ASL, angiosarcoma of the liver, HCC, hepatocellular carcinoma, IARC, International Agency for Research in Cancer, SMR, standardized mortality ratio, AFP, alpha-fetoprotein

 

 The author declared that he is a paid consultant to the European Council of Vinyl Manufacturer’s for the workshop on the relationship between VCM and HCC, a consultant to Bayer and a speaker for Bayer Inc.

PII: S0168-8278(09)00634-5

doi:10.1016/j.jhep.2009.09.012

Journal of Hepatology
Volume 51, Issue 6 , Pages 1074-1081, December 2009